A Feasibility Study to Evaluate the Safety of the KNP-1000 Apheresis System in Severe Preeclampsia
Not Applicable
Not yet recruiting
- Conditions
- Pre-Eclampsia, Severe
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 13
- Registration Number
- NCT06580405
Kaneka Endovascular Embolization and Protection
Not Applicable
Recruiting
- Conditions
- Aneurysm Cerebral
- Interventions
- Device: i-ED COIL
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 164
- Registration Number
- NCT05563051
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸McLaren Health Care, Grand Blanc, Michigan, United States
🇺🇸Northwell Health Lenox Hill Hospital, New York, New York, United States
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
Not Applicable
Recruiting
- Conditions
- Focal Segmental Glomerulosclerosis
- Interventions
- Device: LIPOSORBER® LA-15
- First Posted Date
- 2019-08-22
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 35
- Registration Number
- NCT04065438
- Locations
- 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States
🇺🇸Nemours/Alfred I DuPont Hospital for Children, Wilmington, Delaware, United States
🇺🇸Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
Not Applicable
Recruiting
- Conditions
- Dialysis Amyloidosis
- Interventions
- Device: Lixelle® treatment
- First Posted Date
- 2016-11-02
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 40
- Registration Number
- NCT02952144
- Locations
- 🇺🇸
The Rogosin Institute, New York, New York, United States
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Not Applicable
Recruiting
- Conditions
- Focal Segmental Glomerulosclerosis
- Interventions
- Device: LIPOSORBER® LA-15 System
- First Posted Date
- 2014-09-10
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Kaneka Medical America LLC
- Target Recruit Count
- 35
- Registration Number
- NCT02235857
- Locations
- 🇺🇸
St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
🇺🇸Weill Cornell Medical Center / NewYork-Presbyterian, New York, New York, United States
🇺🇸University of North Carolina, Chapel Hill, North Carolina, United States
© Copyright 2025. All Rights Reserved by MedPath